 Ovarian cancer is a serious challenge in modern gynecological oncology due to its non-specific symptoms and lack of an effective screening procedure. Research is being conducted to identify new markers that could be used in the detection of ovarian cancer to improve early diagnosis and survival rates. This paper reviews current diagnostic markers and the latest selected immunological and molecular parameters being investigated for their potential use in developing new diagnostic and therapeutic strategies. This article was authored by Aleksandra Inglis, Marta SMY CZ Kibanska, and Aleksandra Milksarek-Palix.